Reuters logo
BRIEF-Catalyst Pharmaceuticals reports positive data from investigator-sponsored trial of firdapse
March 15, 2017 / 12:28 PM / 8 months ago

BRIEF-Catalyst Pharmaceuticals reports positive data from investigator-sponsored trial of firdapse

March 15 (Reuters) - Catalyst Pharmaceuticals Inc:

* Catalyst Pharmaceuticals announces positive data from investigator-sponsored trial of firdapse® in treating musk antibody positive myasthenia gravis

* Catalyst Pharmaceuticals Inc- expects additional data to be presented at upcoming medical congresses in 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below